Juliann Ehrhart

Statistics

Publications

Citations

357

H-Index

Active since

2016

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Juliann Ehrhart is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, optimization of pharmacokinetic properties, and medicinal heterocycles.

Publications per year

2016–2017

Publications

Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy

Robert W. Myers, Hong-Ping Guan, Juliann Ehrhart et al. · Science · 2017 · 344 citations

Life Sciences, Biochemistry, Pharmacology +17

Discovery of a potent and selective ROMK inhibitor with improved pharmacokinetic properties based on an octahydropyrazino[2,1-c][1,4]oxazine scaffold

Yuping Zhu, Reynalda K. de Jesus, Haifeng Tang et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 13 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

1–2 of 2